Amy E. Armstrong, MD, Angela Hirbe, MD, PhD - ReiNForcing Care Pathways in NF1-PN: Solutions to Improve Outcomes Across the Patient Journey With MEK Inhibition and Shared-Care Models

About this episode

The episode discusses improving patient outcomes in NF1-PN through MEK inhibition and shared-care models.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NJM865. CME/MOC/AAPA/IPCE credit will be available until May 28, 2027. ReiNForcing Care Pathways in NF1-PN: Solutions to Improve Outcomes Across the Patient Journey With MEK Inhibition and Shared-Care Models In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Neurofibromatosis Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by independent educational grants from Alexion, AstraZeneca Rare Disease and SpringWorks Therapeutics, Inc. Disclosure information is…

People in this episode

Guests: Amy E. Armstrong, MD, Angela Hirbe, MD, PhD

Topics covered

• NF1-PN
• MEK Inhibition
• Shared-Care Models
• Patient Outcomes
• Healthcare Education

Keywords

• NF1-PN
• MEK Inhibition
• Patient Care
• Healthcare Professionals
• CME

Sponsors

Alexion, AstraZeneca Rare Disease, SpringWorks Therapeutics, Inc.

Mentioned in this episode

Organizations: PeerView Institute for Medical Education, Neurofibromatosis Network

More episodes of PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

• Andrew Kuykendall, MD - Ironing Out the Challenges of PV: Spotlight on Targeting the Hepcidin Pathway for Addressing Unmet Needs and Enhancing Patient Outcomes · June 5, 2026 · 32 min
• Brendon M. Stiles, MD - The Immunotherapy Playbook for Resectable NSCLC: Real-World Challenges and Practical Strategies · June 4, 2026 · 1h 6m
• Charise Gleason, MSN, NP-C, AOCNP / Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO - “Off-the-Shelf” Choices in RRMM: Oncology Nurse Guidance on Delivering Quality Care With BCMA and Non-BCMA Immunotherapy · May 29, 2026 · 60 min
• Ibrahim Aldoss, MD - Expanding Bispecific Options for Acute Lymphoblastic Leukemia: From Current Standards to Future Practice · May 29, 2026 · 38 min
• Jaume Capdevila, MD, PhD - Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings · May 29, 2026 · 55 min
• Luke Maese, DO, Rachel Rau, MD - ADAPT to Advance in ALL/LBL: Achieving Durable Asparaginase Exposure With Personalized Treatment in Pediatric and AYA Patients · May 29, 2026 · 49 min